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Extracellular matrixHyperglycemia (HG) reduces AMPK activation leading to impaired autophagy and matrix accumulation. Hydro-
gen sulﬁde (H2S) treatment improves HG-induced renovascular remodeling however, its mechanism remains
unclear. Activation of LKB1 by the formation of heterotrimeric complex with STRAD and MO25 is known to acti-
vate AMPK. We hypothesized that in HG; H2S induces autophagy and modulates matrix synthesis through
AMPK-dependent LKB1/STRAD/MO25 complex formation. To address this hypothesis, mouse glomerular endo-
thelial cells were treated with normal and high glucose in the absence or presence of sodium hydrogen sulﬁde
(NaHS), an H2S donor. HG decreased the expression of H2S regulating enzymes CBS and CSE, and autophagy
markers Atg5, Atg7, Atg3 and LC3B/A ratio. HG increased galectin-3 and periostin, markers of matrix accumula-
tion. Treatment with NaHS to HG cells increased LKB1/STRAD/MO25 formation and AMPK phosphorylation. Si-
lencing the encoded genes conﬁrmed complex formation under normoglycemia. H2S-mediated AMPK
activation in HG was associated with upregulation of autophagy and diminished matrix accumulation. We con-
clude that H2S mitigates adverse remodeling in HG by induction of autophagy and regulation of matrix metabo-
lism through LKB1/STRAD/MO25 dependent pathway.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Hydrogen sulﬁde (H2S) is well known as a potent vasodilator and
signaling molecule under normal and pathophysiological conditions. In
the mammalian tissue, it is produced from L-cysteine by cystathionine
β-synthase (CBS), cystathionine γ-lyase (CSE), 3-mercaptopyruvate
sulfurtransferase (3MST), and cysteine aminotransferase (CAT) [1]. Pre-
viously we reported that in diabetic kidney, H2S is a critical regulator of
MMP-9-induced renovascular remodeling involving connexins-40 and -
43 [2]. H2S treatment has also been shown to regulate interstitial micro-
circulation in diabetic nephropathy [3]. Despite these studies, the exact
mechanism of how H2S mediates these effects remains unknown.
Adenosinemonophosphate-activated protein kinase (AMPK) is a key
regulator of cellular energy status in the body. Under metabolic stress,
activation of AMPK leads to increased glucose uptake, increased expres-
sion of glucose transporter 4 (GLUT4) andmitochondrial biogenesis [4].
The activation of AMPK involves phosphorylation of threonine residue
by an upstream kinase, liver kinase B1 (LKB1) which forms a complex
with two other subunits, STE20-related adaptor (STRAD) and mouseand Biophysics, University of
isville, KY40292, USA. Tel.: +1protein 25 (MO25) [5]. The formation of this tri-molecular complex,
LKB1/STRAD/MO25 is crucial in the LKB1-AMPK signaling pathway for
cell growth and proliferation [5]. Acute hyperglycemia has been report-
ed to reduce AMPK phosphorylation in the kidney and promote protein
synthesis by activation ofmammalian target of rapamycin (mTOR) com-
plex and administration of H2S was found to restore basal AMPK phos-
phorylation and reverse these changes [6,7]. A reduction in AMPK
phosphorylation in type 1 diabetes was shown to induce podocyte apo-
ptosis andworsening of renal injury [8]. Similarly, reduced AMPK activa-
tion has also been demonstrated in human diabetic nephropathy [9]. In
the above study, treatment with 5-aminoimidazole-4-carboxamide-1-
β-D-ribofuranoside, an AMPK activator was found to reduce accumula-
tion of matrix proteins and reduce albuminuria [9]. A recent study has
also suggested that AMPK activation plays an important role in the au-
tophagy mechanism in chronic kidney disease [10].
Autophagy is an evolutionarily conserved process which recycles
damaged or unused proteins and organelles to promote cell survival
under stress conditions and is regulated mainly by mTOR and AMPK
pathways [11,12]. Recent reports suggest that autophagy is defective
in hyperglycemic condition leading to podocyte and proximal tubu-
lar injury causing acceleration of the disease process [13,14]. Upreg-
ulation of mTOR is associated with hypertrophy of glomerular and
tubular epithelial cells and its inhibition using rapamycin was
found to be protective [15–17]. Inactivation of AMPK in diabetes
was associated with similar renal injury which was abrogated by
2817S. Kundu et al. / Biochimica et Biophysica Acta 1843 (2014) 2816–2826metformin, an AMPK agonist [6,18,19]. Recently, we also reported
that induction of autophagy mitigates adverse renovascular remod-
eling in salt-sensitive hypertension [20]. Taken together the above
studies suggest that autophagy plays signiﬁcant role in conditions
associated with excess deposition of extracellular matrix proteins
causing renal ﬁbrosis.
Since hyperglycemia is associated with decreased H2S production
and reduced activation of AMPK, in this study we hypothesized that
1) diminished H2S inhibits LKB1 activation thus decreasing AMPK
phosphorylation, 2) NaHS (H2S donor) treatment phosphorylates
LKB1 by forming a trimolecular complex with STRAD and MO25
leading to AMPK activation, and 3) activation of AMPK induces au-
tophagy and reduces excess matrix deposition in hyperglycemic
condition. Here, we report that H2S treatment mediates its beneﬁcial0
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Fig. 1. Hyperglycemia attenuated H2S production, and CBS and CSE expression. Mouse glomer
(HG) conditions without or with H2S (30 μM) for 24 h. (A, B) H2S concentration in cell lysates a
(C) 100 μg of protein was loaded for Western blot and GAPDH was used as a loading control. (
levels of CBS and CSEweremeasured using 2 μg of RNA extracted fromMGECs as described in Se
change. Data represent mean ± s.e.m. (n = 5). Images are representative of four independenteffects in hyperglycemic condition by activation of LKB1-AMPK sig-
naling which involves the formation of LKB1/STRAD/MO25 complex.
2. Results
2.1. H2S supplementation normalizes H2S levels and CBS and CSE expression
in HG cells
To determine whether hyperglycemia was associated with de-
creased H2S, we measured H2S concentration in the cells and culture
media. There was no difference in H2S concentration in NG cells treated
without or with H2S (Fig. 1A). In contrast, HG cells had low levels of H2S
whichwas restored to normal followingH2S treatment (Fig. 1A). Similar
results were obtained for H2S in culture media (Fig. 1B).0
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D) Pixel densities were quantiﬁed as fold change. (E) RT-PCR ampliﬁcation and transcript
ction 4. GAPDHmRNAwas used as loading control. (F) Pixel densities are presented as fold
experiments performed in triplicate for H2S.
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production, cells were treated with NG or HG in the absence or presence
of H2S. In cellsmaintained at NG, treatmentwithH2S hadno effect on the
expression of CBS and CSE protein (Fig. 1C, D) andmRNA (Fig. 1E, F). HG
abolished the expression of CBS and CSE protein and mRNA which was
normalized following H2S treatment (Fig. 1C–F).
2.2. H2S normalizes expression of STRAD and MO25 in HG cells
Activation of AMPK is regulated by an upstream serine/threonine ki-
nase LKB1. Since LKB1 activation and translocation from nucleus re-
quires STRAD and MO25, we ﬁrst determined the effects of HG and
H2S on the expression of STRAD and MO25. Western blot showed
basal expression of STRAD and MO25 in NG cells which did not change
upon treatment with H2S (Fig. 2A, B). However, HG decreased the ex-
pression of STRAD and MO25 which was restored following H2S treat-
ment (Fig. 2A, B). STE-20 related adaptor protein-α (Stradα) and
calcium binding protein 39 (Cab39) regulate the expression of STRAD
andMO25 proteins, respectively [21,22]. To determinewhether protein
expression correlates with gene expression, we measured Stradα and
Cab39 mRNA by semiquantitative PCR. Similar to protein expression
above, there was basal expression of Stradα and Cab39 mRNA in NG
which was not affected by treatment with H2S (Fig. 2C, D). HG caused
a signiﬁcant decrease in STRAD and MO25 expression which was re-
stored following H2S treatment (Fig. 2C, D).
Immunostaining further conﬁrmed basal expression and co-
localization of STRAD and MO25 in NG cells which was unaffected fol-
lowing H2S treatment (Fig. 2E). However, in HG cells their expression
was signiﬁcantly decreased andH2S treatment normalized their expres-
sion (Fig. 2E).
To conﬁrm the above data, we used siRNA technology to knock
down STRAD, MO25, or LKB1 and determined the complex formation.
As shown in Supplementary Fig. 2F, knockdown of STRAD or MO25 by
siRNA effectively decreased its respective protein expression compared
to cells treated with scrambled siRNA in NG condition. Furthermore,
knockdown of LKB1 by siRNA showed basal expression of STRAD and
MO25. Treatment of NG cells with H2S failed to restore basal expression
of individual kinases involved in the complex formation (Supplementa-
ry Fig. 2G).
2.3. H2S normalizes LKB1/STRAD/MO25 complex formation in HG cells
To conﬁrm the formation of LKB1/STRAD/MO25 complex, we used
co-immunoprecipitation followed by Western blot. Cell lysates were
immunoprecipitated with STRAD antibody followed by probing with
MO25 (Fig. 3A) and LKB1 (Fig. 3B). Similarly, other possible combina-
tions were done as shown in Fig. 3C–F in NG and HG conditionswithout
and with H2S. In NG cells treated without or with H2S, STRAD, MO25,
and LKB1 individually were able to precipitate the other members of
the complex. In HG cells, the complex was not detected suggesting the
lack of formation of the complex or decreased expression of the proteins
involved in complex formation. Treatmentwith H2S restored the associ-
ation of the complex similar to NG cells (Fig. 3A–F).
2.4. H2S normalizes HG-induced decrease in phosphorylation of LKB1 and
AMPK
Since activation of LKB1 is essential for AMPK phosphorylation and
subsequent autophagy, we measured the phosphorylation status of
LKB1 and AMPK as surrogate for activation in cells treated with NG or
HG in the presence or absence of H2S. As shown in Fig. 4 immunoblot-
ting (A and B) and immunoﬂuorescence (C) showed that under basal
(NG) conditions both LKB1 and AMPK are phosphorylated. Treatment
with H2S had no signiﬁcant effect on the phosphorylation of LKB1 and
AMPK in NG cells (Fig. 4A, B). In contrast MGECs treated with HG,
showed minimal phosphorylation of LKB1 and AMPK compared to NGtreated cells (Fig. 4A, B). Interestingly, H2S treatment to HG cells re-
stored phosphorylation of LKB1 and AMPK to levels observed in NG
cells (Fig. 4A, B).
To determine the formation of LKB1/STRAD/MO25 complex and
subsequent AMPK phosphorylation we used siRNA to knock down re-
spective kinases and measured the phosohorylation of LKB1 and
AMPK by immunoﬂuorescence in NG cells. As shown in Supplementary
Fig. 4D, no basal phosphorylationwas detected for both LKB1 and AMPK
compared to levels seen in NG cells using scrambled siRNA as control.
Treatment with H2S failed to restore LKB1 and AMPK phosphorylation
further conﬁrming the lack of complex formation (Supplementary
Fig. 4E).
2.5. H2S restores HG-induced decrease in AMPK activity
The above data suggest that HG decreases LKB1/STRAD/MO25 com-
plex formationwhich is required for AMPK activation. To determine the
effect of H2S on AMPK activation, we determined AMPK activity in NG
and HG cells in the presence or absence of H2S. As shown in Fig. 5,
there was basal activity of AMPK in NG cells which was not affected
by treatment with H2S. In contrast, HG cells had signiﬁcantly lower
AMPK activity as compared to NG cells. Interestingly, treatment with
H2S signiﬁcantly upregulatedAMPK activity inHGcells compared to un-
treated cells. Furthermore, knock-down of any member of the LKB1/
STRAD/MO25 complex in NG cells both in the absence or presence of
H2S blocked the activation of AMPK (Fig. 5). Additionally, siRNA inhibi-
tion of AMPK showed diminished activity in NG conditions without or
with H2S treatment (Fig. 5).
2.6. H2S normalizes HG-induced impaired autophagy
Impaired autophagy results in accumulation of abnormal degrada-
tion products including extracellular matrix proteins. We therefore
measured the effect of H2S on the expression of autophagy markers,
viz; mTOR, Atg5, Atg7, Atg3 and LC3B/A ratio in NG and HG cells. In
NG cells mTOR levels were low whereas, Atg5, Atg7, and Atg3 were
expressed at baseline levels which was unaffected following H2S treat-
ment. However, in HG cells there was a signiﬁcant decrease in Atg5,
Atg7, and Atg3 expression and LC3B/A ratio, and a signiﬁcant increase
in mTOR expression (Fig. 6A–D). Treatment with H2S to HG cells re-
stored the expression of Atg5, Atg7, Atg3 and LC3B/A ratio to basal
levels, and decreased mTOR expression. Semi-quantitative PCR con-
ﬁrmed mRNA levels with their protein expression in NG and HG condi-
tions without or with H2S treatment (Fig. 6E–H).
Hyperglycemia induces mTORC1 activation which controls the
synthesis of initiation and elongation factors of mRNA translation.
In order to conﬁrm mTORC1 activation, we measured the phosphor-
ylation status of 4E-BP1 at serine 65 position. There was basal phos-
phorylation in NG cells which did not change with H2S treatment
(Fig. 6I, J). In contrast, therewas robust increase in 4E-BP1 phosphor-
ylation in HG cells which was restored to NG levels following H2S
treatment (Fig. 6I, J).
2.7. H2S decreases HG-induced galectin-3 and periostin overexpression
Accumulation of matricellular proteins is associated with matrix
remodeling. Wemeasured the expression of galectin-3 and periostin
as surrogate markers for matrix remodeling. In HG cells, the expres-
sion of both galectin-3 and periostin was increased (Fig. 7A, B) and
treatment with H2S normalized their expression to the levels ob-
served in NG cells (Fig. 7A, B). To determine if the increase in matrix
protein expression is dependent upon AMPK activation, HG cells
were treated with an AMPK activator, phenformin. As shown in
Fig. 7, treatment with phenformin normalized expression of
galectin-3 and periostin in HG cells. DMSO had no effect on expres-
sion of galectin-3 and periostin.
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Several pathogenic processes contribute to the development of glo-
merular and tubulointerstitialﬁbrosis in diabetic nephropathy. A reduc-
tion in hydrogen sulﬁde has been reported to cause excess matrixprotein deposition and hypertrophy in diabetic kidneys and exogenous
administration of H2S ameliorated the effects of hyperglycemia [7]. Pre-
viously, we demonstrated that H2S treatment in HG reduced MMP-9-
induced diabetic renal remodeling by downregulation of connexins
[2]. However, the mechanism by which H2S mediates these effects is
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2820 S. Kundu et al. / Biochimica et Biophysica Acta 1843 (2014) 2816–2826unknown. In the present study, we report a novel signaling mecha-
nism of H2S-induced autophagy and reduction in matricellular pro-
tein synthesis in mouse glomerular endothelial cells (MGECs)
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2821S. Kundu et al. / Biochimica et Biophysica Acta 1843 (2014) 2816–2826We show for the ﬁrst time that administration of H2S in HG causes
phosphorylation and activation of LKB1 by the formation of a
heterotrimeric complex with STRAD and MO25 leading to AMPK ac-
tivation, induction of autophagy, and degradation of matrix proteins.
In addition to its role as a modulator of cardiovascular and neuronal
signaling, hydrogen sulﬁde has been shown to regulate renal function
[23]. In diabetes, deﬁciency of hydrogen sulﬁde is associated with
renal injury whereas, its supplementation has been reported to attenu-
ate glomerular lesions and improve local blood ﬂow in the capillaries
around the proximal tubules [3,24]. In addition, treatment of diabetic
ratswithH2S donor, NaHS, has been shown to decrease TGF-βmediated
collagen IV synthesis in the kidney [25]. Furthermore, Lee et al. demon-
strated that H2S administration to cultured glomerular epithelial cells
reduces hypertrophy and matrix protein synthesis under hyperglyce-
mic conditions [7]. More recently, we demonstrated that H2S deﬁciency
in type 1 diabeticmice andmouse glomerular endothelial cells (MGECs)
was associated withMMP-9-activation and renal remodeling and treat-
ment with H2S abrogated the adverse effects [2]. The results from the
present study conﬁrms previous ﬁndings regarding decreased CBS/CSE
levels and H2S during hyperglycemia and the beneﬁcial effect that H2S
provides in diabetic kidney disease. Interestingly, H2S treatment to HG
cells increased the expression of CBS and CSE at protein and mRNA
level. H2S exerts a variety of physiological functions in the body by sev-
eral intracellular signaling mechanisms. In a recent study involving hy-
drogen peroxide-induced injury in human umbilical vein endothelial
cells, NaHS treatment was reported to increase CSE expression and ac-
tivity both at protein and mRNA level [26]. In another study involving
unilateral ureteral obstruction induced renal ﬁbrosis in mice; Jung
et al. reported decreased expression of CBS and CSE in the kidney [27].
However, following NaHS treatment, the expression of CBS and CSE
was found to be signiﬁcantly increased [27].
Previous studies have demonstrated that administration of NaHS
(H2S donor) increased the expression of endothelial nitric oxide syn-
thase and nitric oxide (NO) production in in vitro and in vivo experi-
ments [28,29]. In an earlier study on the role of H2S on cardiovascular
tissue, Zhao et al. showed that NO donor treatment increased H2S pro-
duction in rat aorta and smooth muscle cells isolated from the aorta.
This was associated with increased expression of CSE mRNA [30].Although the exactmechanismof hownitric oxide increases the expres-
sion of CSE is not known, the author suggests this possibility as essential
evidence for H2S-mediated physiological functions [31]. Furthermore,
emerging evidence suggests signiﬁcant crosstalk between the three en-
dogenous gasotransmitters, H2S, NO and carbon monoxide [32]. It is
possible that such interactions could promote the upregulation of either
enzymes leading to increased H2S production, however, further studies
are required to unravel the underlying mechanisms.
It is well documented that AMPK plays a key role in maintaining
glucose homeostasis. The activation of AMPK has multiple effects in
several organs including increased glucose uptake by reducing insu-
lin resistance, increasing fatty acid oxidation and mitochondrial bio-
genesis [33]. In mice fed with high-fat diet, reduction in renal AMPK
activity was associated with an inﬂammatory response in the early
stages of kidney disease and treatment with AMP activator, 5-
aminoimidazole-4-carboxamide-1-β-D-ribonucleoside prevented
renal hypertrophy [34]. Recent studies provide evidence that H2S in-
duces AMPK activation in hyperglycemia to modulate neuroinﬂam-
mation, reduce oxidative stress and vascular inﬂammation [35,36].
Furthermore, in vitro studies on glomerular epithelial cells showed
that NaHS treatment increased AMPK phosphorylation and inhibited
excess protein synthesis due to hyperglycemia [7]. In agreement
with the above studies, we found increased AMPK phosphorylation
following H2S treatment. The activation of AMPK occurs mainly by
two upstream kinases: a) calcium/calmodulin-dependent protein ki-
nase kinase β (CaMKKβ) and b) AMP-dependent liver kinase B1
(LKB1). Previous studies report that CaMKKβ accounts for H2S medi-
ated AMPK phosphorylation in glomerular epithelial cells and BV2
microglia [7,35]. In contrast, our results suggest that H2S-mediated
AMPK phosphorylation occurs via LKB1 activation in glomerular en-
dothelial cells. Although we did not study CaMKKβ mediated AMPK
phosphorylation, transfection of MGECs with siRNA for LKB1 signiﬁ-
cantly inhibited phosphorylation of AMPK suggesting this as the pre-
dominant mechanism in mouse glomerular endothelial cells.
Liver kinase B1 is an upstream kinase of AMPK which is involved in
maintaining cell polarity and suppression of inappropriate cell prolifer-
ation under stress conditions. The localization and activity of LKB1 is de-
pendent on its interaction with two pseudokinases, STRADα andMO25
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2823S. Kundu et al. / Biochimica et Biophysica Acta 1843 (2014) 2816–2826which is crucial for AMPK activation. STRADα directly associates with
LKB1 at its kinase domain which allows for the translocation of LKB1
from the nucleus to cytoplasm [37] and MO25 binds to the C-terminal
residue of STRAD and acts as a scaffold to support the formation of
heterotrimeric complex (LKB1/STRAD/MO25) [38]. The loss of LKB1 ac-
tivity in adult mouse liver leads to complete loss of AMPK activity and is
associated with hyperglycemia [39,40]. In the present study, H2S treat-
ment in hyperglycemia was associated with the formation of LKB1/
STRAD/MO25 complex and AMPK phosphorylation (Figs. 2E and 4C).
This was further conﬁrmed by the inability of complex formation and
activation of AMPK when MGECs were knocked down for LKB1,
STRAD andMO25 genes under normoglycemia includingH2S treatment
(Figs. 2F, G and 4D, E).
Autophagy is a highly conserved catabolic process which maintains
cellular homeostasis under stress conditions by degradation and
recycling intracellular components [41]. Autophagy begins with the for-
mation of a phagophore membrane which is derived from endoplasmic
reticulum and is followed by Atg5–Atg12 conjugation [42]. Ubiquitin-
like enzymes, Atg7 and Atg10 play a key role in the activation and con-
jugation of Atg5–Atg12which then complexes with Atg16L and recruits
microtubule-associated protein light chain 3 (LC3B) [41]. Further cleav-
age and activation of LC3B-I by Atg7 is processed by Atg3 and phospha-
tidylethanolamine generating LC3B-II. The integration of LC3B-II
enables fusion ofmembranes and engulfment of proteins and organellesFig. 6.H2Smodulated autophagy in hyperglycemia (HG). Protein expression for autophagymark
used as a loading control. (E and G) Gene expression of autophagymarkers was detected by RT-
The band intensities of protein (A and C) andmRNA (E and G) expressionwere quantiﬁed using
single experiment and bar graphs representmean± s.e.m. fromﬁve independent experiments (
expression of phospho-4E-BP1 was measured by Western blot analysis using GAPDH as c
(mean ± s.e.m., n = 3) (J).for degradation [42]. Increased level of LC3B-II is an indicator of autoph-
agy induction. In hyperglycemia, excess nutrient status causes down-
regulation of autophagy leading to accumulation of proteins in
glomerular basementmembrane and proximal tubules [43,44]. Because
AMPK is an energy sensor in the cell, during glucose sufﬁciency AMPK is
inactive, whereas, its target, mTOR becomes activated causing phos-
phorylation of Ulk1 which in turn prevents the interaction between
Ulk1 and AMPK thus inhibiting autophagy [45]. Our results showing in-
creased mTOR expression and decreased autophagy markers (Fig. 6A–
H) are in concurrence with these earlier reports. The phosphorylation
of AMPK by H2S treatment increased the expression of Atg5, Atg7 and
Atg3 and LC3B suggesting induction of autophagy.
Several studies have shown that mTOR signaling is involved in pro-
tein synthesis and renal hypertrophy [15,46]. mTOR has been shown to
regulate the initiation and elongation phases in the protein translation
process. In vitro studies on human embryonic kidney cells has shown
that pre-treatment with rapamycin, anmTOR inhibitor signiﬁcantly de-
creases protein synthesis implying a key role for mTOR signaling in this
process [47]. In thepresent study,we conﬁrmed increased4E-BP1phos-
phorylation, a downstream target of mTOR, suggestingmTORC1 activa-
tion during hyperglycemia and its reduction following H2S treatment.
Furthermore, AMPK has been shown to control the phosphorylation of
several other enzymes involved in protein synthesis. For example,
when cardiomyocytes were treated with AMPK activators, metforminers,mTOR, Atg5, Atg7 (A), andAtg3 and LC3A/B (C)weremeasured inMGECs. GAPDHwas
PCR ampliﬁcation using 2 μg of RNA from cells. GAPDHmRNAwas used as loading control.
ImageJ software and presented as fold change (B, D, F and H). Images are representative of
n=5).MGECswere incubated inNG orHG conditionwithout orwithH2S for 24 h. Protein
ontrol (I). Band intensities were quantiﬁed by ImageJ and presented as fold change
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synthesis was signiﬁcantly inhibited [48]. During hyperglycemia, the
combined effects ofmTOR activation and AMPK inhibition enhance pro-
tein synthesis leading to basement membrane thickening and expan-
sion of the mesangium [49]. Periostin and galectin-3 have been
identiﬁed as markers associated with vascular remodeling and disease
progression in diabetic nephropathy [50,51]. In this study, we demon-
strate that the expression of both proteins was markedly increased in
HG condition suggesting their role in matrix remodeling and H2S treat-
ment normalized their expression supporting our hypothesis that H2S
has the potential to prevent renovascular remodeling caused by
hyperglycemia.
In conclusion, the present study demonstrates that hyperglycemia
impairs H2S production and AMPK phosphorylation. The activation of
AMPK which is dependent on the activation of LKB1, an upstream ki-
nase is reduced due to the inability of LKB1 to form a heterotrimeric
complex (LKB1/STRAD/MO25). Inactive AMPK inhibited autophagy by
upregulation of mTOR and increased matrix protein accumulation. We
demonstrate for the ﬁrst time that for H2S-induced AMPK activation,
LKB1 requirement and the formation of heterotrimeric complex with
STRAD and MO25 is essential and selective for glomerular endothelial
cells. The downstream effects of AMPK activation inhibited protein syn-
thesis and induced autophagy for clearance of excess matrix proteins to
prevent matrix remodeling in HG condition.
3.1. Limitation of the study
Activation of AMPK is regulated mainly by calcium-dependent cal-
modulin kinase kinase beta (CamKKβ) and AMP-dependent liver kinase
B1 (LKB1).
Previous reports suggest that H2S mediated AMPK activation occurs
via CamKKβ in glomerular epithelial cells and BV2 microglia [7,35].
However, in a recent study involving human umbilical vein endothelial
cells and bovine aortic endothelial cells, metformin induced AMPK
phosphorylation required LKB1 for its activation [52]. Although our
study shows that AMPK activation occurs via LKB1 phosphorylation in
MGECs,whether the activation of AMPKunder similar conditions occurs
by CamKKβ remains to be investigated. However, the absence of LKB1/
STRAD/MO25 complex formation after knockdown of respective genes
suggests that this may be the predominant mechanism in MGECs.
4. Materials and methods
4.1. Cell culture
Mouse glomerular endothelial cells (MGECs) and complete media
kit (Cat. No. M1168) were purchased from Cell Biologics, Inc. (Chicago,
IL). Cells were maintained at 37 °C in a humidiﬁed atmosphere with
5% CO2 in complete media. Cells were plated onto six-well culture
dishes and all experiments were carried out at 80–85% conﬂuence.
4.2. Cell treatment
Cellswere divided into two groups: Group 1: treatedwith 5mMglu-
cose; designated as normoglycemic or NG, and Group 2: treated with
25 mM glucose for 24 h; designated as diabetic or hyperglycemic or
HG. Where reported, the groups were treated without or with NaHS
(30 μM, as a source of instant H2S) for 24 h. At the end of experimenta-
tion, cells were washed with PBS, collected and used for various tests
and analysis as reported.
4.2.1. Gene silencing by siRNA transfection
Pre-designed small interfering RNA (siRNA) targeting STRAD,MO25,
LKB1, AMPKα1/2, and control siRNAs were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). The transfection procedure was per-
formed using DNA transfection reagent (jetPRIME, France) accordingto the manufacturer's instructions. Brieﬂy, MGECs were seeded onto a
six-well culture plates (TPP, USA) and allowed to reach 60% conﬂuence.
Transfection reagents were prepared by adding 200 μl of jetPRIME buff-
er, 100 pmol of siRNA and 4 μl of jetPRIME reagent. After mixing, the
ﬁnal solution containing 10 nM of siRNA was added to the wells and
allowed to grow for 24 h and followed by experimental conditions.
4.3. Antibodies and reagents
Rabbit polyclonal antibodies to cystathionine β-synthase (CBS), cys-
tathionine γ-lyase (CSE), STE-20 related adapter protein α (STRAD),
mouse protein 25 (MO25), phosphorylated LKB1 (p-LKB1), phosphory-
lated AMPK (p-AMPK), galectin-3, periostin, phosphorylated 4E-BP1 (p-
4E-BP1, Ser 65); horseradish peroxidase (HRP)-linked anti-rabbit IgG
antibody and siRNAs were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-Atg3, anti-Atg5, anti-Atg7, anti-mTOR, and anti-
GAPDH antibodies were purchased from Cell Signaling Technology,
Inc. (Danvers, MA). Anti-LC3A/B antibodywas fromAbcam (Cambridge,
MA). NaHS and other analytical reagents were purchased from Sigma-
Aldrich (St. Louis, MO). Polyvinylidene ﬂuoride (PVDF) membrane
was from Bio-Rad (Hercules, CA). Phenformin hydrochloride was pur-
chased from Sigma Aldrich (St. Louis, MO)
4.4. H2S measurement
H2S was measured from both cell extracts and culture media. After
treatment, the media was collected and kept in an air-tight tube to pre-
vent H2S loss. Cells were extracted in ice-cold PBS, collected in 1.5 ml
Eppendorf tube, and sealed immediately with paraﬁlm. H2S measure-
ment was originally described by Stipanuk and Beck [53]. We used the
modiﬁed protocol to measure acid-labile sulfur as described by Lu
et al. [54]. Brieﬂy, samples were sonicated and 100 μl aliquots were
mixed with PBS (pH 7.4, 350 μl) and zinc acetate (1% w/v, 250 μl) in a
micro-centrifuge tube. This was followed with the addition of N,N-di-
methyl-p-phenylenediamine sulfate (20 mM, 133 μl) in 7.2 M HCl, and
FeCl3 (30 mM, 133 μl) in 1.2 M HCl. Tubes were sealed and incubated
at 37 °C for 45 min. The reaction was terminated by the addition of tri-
chloroacetic acid solution (10% w/v, 250 μl) and following centrifuga-
tion, the supernatant was transferred to a 96-well plate and the
absorbance was measured at 670 nm in a spectrophotometer. All sam-
pleswere assayed in duplicate in each experiment andH2Swas calculat-
ed against a calibration curve of known concentrations of NaHS (0.01–
100 μmol/L).
4.5. Protein extraction and Western blot analysis
Total protein was extracted using RIPA buffer (Boston BioProducts,
Worcester, MA) with 1 mM phenylmethanesulfonyl ﬂuoride (PMSF)
and 1% protease inhibitor cocktail (Sigma, St. Louis, MO). Following mea-
surement of protein concentration, 100 μg of protein was separated by
SDS-PAGE and electro-transferred to PVDF membrane. The membranes
were probed with primary antibodies against CBS, CSE, STRAD, MO25,
p-LKB1, p-AMPK, autophagy markers, galectin-3 and periostin, p-4E-BP1
and HRP-conjugated appropriate secondary antibodies. Blots were devel-
oped with enhanced chemiluminescence (Thermo Scientiﬁc, Rockford,
IL). Band intensity was analyzed by ImageJ (http://imagej.nih.gov/ij/)
4.6. RNA extraction and quality assessment
MGECswerewashedwith ice-cold PBS and RNAwas extracted using
TRIzol reagent isolation kit following manufacturer's protocol (Life
Technologies, Grand Island, NY). Cells from six separate wells (in a 12
well plate) of the same groupwere pooled, and used as n= 1. The qual-
ity of total RNA was measured by NanoDrop ND-1000 and only high
quality RNA (260/280-2.00 and 260/230-1.80) was used for reverse
transcriptase PCR.
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The total RNA (2 μg) was reverse transcribed by a two-step process
using Promega ImProm RT-PCR kit. Incubation of RNA with oligo dT at
70 °C for 5.00 min. The RT cycle was 25 °C for 2.00 min, 42 °C for
50.00 min, 75 °C for 5.00 min, 4 °C forever. PCR program for ampliﬁca-
tion of cDNA was 95 °C for 10.00 min (95 °C for 00.30 min, 55 °C for
1.00 min, 72 °C for 00.30 min) × 46 cycles, 95 °C for 1.00 min, 55 °C
for 00.30 min and 95 °C for 00.30 min. The primer sequences and
their accession numbers are presented in Table 1.
4.8. Immunostaining
Cells in eight-well chamber slide were gene silenced with appropri-
ate siRNAs, and incubated in NG or HG condition without or with H2S
treatment as shown in the ﬁgures. Immunostaining was performed ac-
cording to the standard protocol. Brieﬂy, after ﬁxation with 4% parafor-
maldehyde, cells were premeabilized with PBS containing 0.25% Triton
X-100 for detection of proteins in the cytoplasmic domain (Abcam,
Cambridge, MA). Primary antibodies were applied overnight and in-
cluded STRAD, MO25, p-LKB1 and p-AMPK. Secondary antibodies la-
beled with either Alexa Fluor-488 or - 594 (Invitrogen) were applied
for immunodetection of proteins or their phosphorylated forms. Stained
slides were visualized and analyzed for ﬂuorescence intensity under a
laser scanning confocal microscope (Olympus FluoView1000) using ap-
propriate ﬁlter.
4.8.1. Determination of AMPK activity
AMPK activity assay was measured as described previously [55].
Cells were washed twice with PBS, pH 7.4, and lysed in lysis buffer
(20 mM Tris, pH 7.4, 150 mM NaCl, 20 mM NaF, 1 mM EGTA, 1 mM
EDTA, 10 μl/ml protease inhibitor cocktail 1, 10 μl/ml phosphatase
inhibitor cocktail 1, 0.5% Nonidet-40, and 1% Triton X-100). The ly-
sates were sonicated for 3 × 10 s on ice at 10 s interval in-between
each sonic pulse. AMPK activity was determined according to the
manufacturer's protocol (Millipore, Billerica, MA). Brieﬂy, 1 ml of
working solution containing γ32P-ATP: 10 μl γ32P-ATP 10mCi/ml (spe-
ciﬁc activity 158–160 CPM/pmol of ATP), 10 μl of ATP (100mM), 25 μl of
magnesium chloride (MgCl2) 1 M, 955 μl of HEPES–Brij buffer (50 mM
Na HEPES, 1 mM dithiothreitol and 0.2 g Brij 35, 0.02%) was prepared.
A positive (10 μl of working solution, 10 μl 1 mM AMP and 10 μl SAMS
peptide 100 μM) and negative (10 μl of working solution, 10 μl 1 mM
AMP and 10 μl HEPES–Brij buffer) master mix solution was prepared
prior to the experiment (30 μl for each sample). The master mix solu-
tions, one negative and two positive were added to three sample ali-
quots from the same group. Activated AMPK (50 mU, Richmond, VC,
Canada) was added to two separate tubes to serve as control. The sam-
ples were transferred to a 30 °C shaker bath for 20 min. at 350 RPM.Table 1
Primers used to amplify mRNAs encoding genes for H2S production, pseudokinases, autophagy
Primer Accession no. Forw
CBS NM_144855.3 TGC
CSE AY083352.1 GAC
Stradα (STRAD) NM_001252449.1 CAC
Cab39 (MO25) NM_133781.4 CGG
mTOR NM_020009.2 CAT
Atg5 NM_053069.5 ACT
Atg7 NM_001253717.1 CAT
Atg3 NM_026402.3 TCC
Map1lc3a (LC3A) NM_025735.3 AAG
Map1lc3a (LC3B) NM_026160.4 GGT
GAPDH M32599.1 TAA
CBS: cystathionine beta synthase, CSE: cystathionine gamma lyase, Stradα: STE20-related kinas
target of rapamycin, Atg5: autophagy related 5, Atg7: autophagy related 7, Atg3: autophagy rela
protein 1 light chain 3β, GAPDH: glyceraldehyde-3 phosphate dehydrogenase.After incubation, each sample was transferred to a numbered P81
phosphocellulose paper. After drying, the papers were washed thrice
with 1% (v/v) phosphoric acid and ﬁnally with acetone. After re-
drying they were transferred to scintillation vials. Bound radioactivity
was quantitated by the addition of 3 ml of scintillation ﬂuid and read
in a scintillation counter (Pharmacia). A substrate control was mea-
sured to correct for nonspeciﬁc binding along with the samples. AMPK
activity was measured by subtracting control counts from the sample.
The activity is expressed as pmoles of phosphate incorporated into the
AMPK substrate peptide per minute per milligram protein.
4.9. Co-immunoprecipitation assay
Co-immunoprecipitation was followed by Western blot to con-
ﬁrm protein–protein interactions with all possible combinations be-
tween LKB 1, STRAD and MO25. Brieﬂy, 100 μg of protein was mixed
with antibodies to LKB1, STRAD and MO25 separately and the ﬁnal
volume made up to 150 μl with 1× PBS. Gelatin–sepharose 4B
beads (Pharmacia LKB Biotechnology Ab Uppsala, Sweden) pre-
soaked in PBS were added to the protein–antibodymixture and incu-
bated overnight at 4 °C in a rotating shaker. The tubes were centri-
fuged at 12,000 RPM for 15 min and supernatant was discarded.
The pellet was blocked with 1% BSA for 45 min and washed thrice
with ice-cold PBS. Washed pellets were re-suspended in 25 μl of 6x
sample buffer and boiled at 95 °C for 5 min to dissociate bound pro-
teins. The sample buffer was loaded to SDS-PAGE, immunoblotted
and probed separately with antibodies.
4.10. Statistical analysis
Statistical analysis was performed using Primer of Biostatistics
(Ver. 7; McGraw-Hill, Blacklick, OH). All results are presented as
the mean ± standard error of the mean (s.e.m.). Multiple comparisons
were analyzed using analysis of variance followed by Bonferroni's post
hoc test. Mann–Whitney rank sum test was performed for ordinal
data. The threshold for signiﬁcance was p b 0.05.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.08.005.
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ard primer (5′–3′) Reverse primer (3′–5′)
GGAACTACATGTCCAAG TTGCAGACTTCGTCTGATGG
CTCAATAGTCGGCTTCGTT CAGTTCTGCGTATGCTCCGTAA
AACTTTGTGGAACAGTG AAGATTCCACTGTGATCCTG
AGACGAAGCAGAGA CTTGTGAGACTTGCCAAATG
TCATTGGAGACGGTTTG AGATGTTGCCTGCTTGATAA
GGGACTTCTGCTCC GTTCTTCCTTCAACCAAAGC
ACAGGCCTCTGGAAAAT CTACTGTTCTTACCAGCCTC
TGTCAGAAGGTTCTAGT GCTAGTTCTGACACTGGTAG
AAACCTTCGGCTTCTGAGTC AAATGACCACAGATCCATACACC
AGACTGCAAGTCCAATGCTC CAGGAATCCTTACTGATCGCAC
ATTTAGCCCGTGTGACCT AGGGGAAAGACTGAGAAAAC
e adaptor alpha, Cab39: calcium binding protein 39 (gene for MO25), mTOR: mammalian
ted 3, LC3A:microtubule-associatedprotein 1 light chain 3α, LC3B:microtubule-associated
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